Skip to main content

Communiqué Orange : Orange signs a joint agreement to acquire SFR, a decisive step that will reinforce its leadership in France

Press releaseParis, 6 June 2026 Orange signs a joint agreement to acquire SFR, a decisive step that will reinforce its leadership in France Orange, alongside Bouygues Telecom and the Free–iliad Group (taken as a group, the “Consortium”), today announce the signing of a Memorandum of Understanding with Altice France for the acquisition of SFR1, France’s second-largest telecommunications operator. This acquisition is in line with Orange’s consolidation strategy in Europe and will enable the Group to reinforce its leadership position in the French market. Once completed, the operation will accelerate value creation for the Group’s stakeholders and will strengthen its capacity to invest in digital infrastructure and services. This transformational transaction would preserve a highly competitive ecosystem and reinforce the sector’s long-term...

Continue reading

Communiqué Orange : Signing of a Memorandum of Understanding for the acquisition of SFR

Press releaseParis, 6 June 2026 Signing of a Memorandum of Understanding for the acquisition of SFR Bouygues Telecom, the Free–iliad Group and Orange (the “Consortium”) announce today the signing of a Memorandum of Understanding with Altice France (the “Seller”) with a view to acquiring SFR, one of the largest industrial transactions in Europe in the telecommunications sector. The proposed transaction aims to create long-term value for all stakeholders — customers, employees, partners, suppliers and investors — and for France by supporting the continued development of its infrastructure and digital ecosystem. This transformational transaction would preserve a highly competitive ecosystem and reinforce the sector’s long-term capacity to invest, innovate and anticipate major technological changes. By enabling each operator to scale up and...

Continue reading

Bouygues Telecom takes a major step forward for its future growth by signing, alongside Free-iliad Group and Orange, a Memorandum of Understanding with Altice France with a view to acquiring SFR

Press releaseParis, 6 June 2026 Bouygues Telecom takes a major step forward for its future growth by signing, alongside Free-iliad Group and Orange, a Memorandum of Understanding with Altice France with a view to acquiring SFR.         Bouygues Telecom today has signed a Memorandum of Understanding, alongside Orange and Free-iliad Group (the “Consortium”), with Altice France with a view to acquiring SFR. This MoU covers the acquisition of the majority of assets operated by Altice France-SFR, excluding shareholdings in XP Fibre, Ultraedge and Altice Technical Services, as well as the Altice France group’s operations in the French overseas departments and regions. An industrial project to support customers, investment and digital sovereignty In a mature telecoms market and an increasingly digital economy, the needs of B2C, B2B and public...

Continue reading

Signing of a Memorandum of Understanding for the acquisition of SFR

Press releaseParis, 6 June 2026 Signing of a Memorandum of Understanding for the acquisition of SFR Bouygues Telecom, the Free–iliad Group and Orange (the “Consortium”) announce today the signing of a Memorandum of Understanding with Altice France (the “Seller”) with a view to acquiring SFR, one of the largest industrial transactions in Europe in the telecommunications sector. The proposed transaction aims to create long-term value for all stakeholders — customers, employees, partners, suppliers and investors — and for France by supporting the continued development of its infrastructure and digital ecosystem. This transformational transaction would preserve a highly competitive ecosystem and reinforce the sector’s long-term capacity to invest, innovate and anticipate major technological changes. By enabling each operator to scale up and...

Continue reading

Real-World Evidence of Eversense 365 Presented at ADA Demonstrating Strong Performance and Patient Impact in Both Open and Closed Loop Systems

Eversense 365 delivered favorable glucometrics compared to other open and closed loop systems, validating the one-year CGM’s differentiated approach and high performance  New data expands on findings shared at ATTD and reinforces Eversense 365’s strong patient adherence, glucometrics and hypoglycemic outcomes across an entire year GERMANTOWN, Md., June 06, 2026 (GLOBE NEWSWIRE) — Senseonics Holdings, Inc. (NASDAQ: SENS), a medical technology company focused on the development, manufacturing and commercialization of long-term, implantable Continuous Glucose Monitoring (CGM) Systems for people with diabetes, today announces further data from a large real-world evidence study which reveals sustained accuracy, performance and positive impact of Eversense 365 in both open-loop and closed-loop systems. The findings were presented during...

Continue reading

All In FutureTech Alliance Provides Strategic Updates: Hainan AIFA Digital Industrial Park, Silicon Photonics Compute Center Planning, and Cross-Border Optical Network Integration

NEW YORK, June 06, 2026 (GLOBE NEWSWIRE) — All In FutureTech Alliance (Nasdaq: AIFA) (“AIFA” or the “Company”) today provided a strategic update. Following the Company’s previously announced signing of agreements to acquire a controlling interest in HyalRoute Communication Group (“HyalRoute”) and advancement of the Hainan AIFA Silicon Photonics Supercomputing Center project, the Company is further accelerating project planning, policy coordination, financing arrangements, and cross-border resource integration around its dual-engine strategy of an “AI infrastructure network powered by optical technologies” and an “AI application services matrix.” The Company stated that, on June 5, AIFA Chairman and Chief Executive Officer James Li met at Morgan Stanley’s Hong Kong headquarters with senior executives of Morgan Stanley and a delegation...

Continue reading

Cullinan Therapeutics Presents Initial Clinical Data for CLN-978, a CD19xCD3 T Cell Engager, at the EULAR 2026 Congress

Clinical benefit, including remissions, demonstrated in both systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) patients following a single target dose of CLN-978  Deep, dose-dependent B cell depletion observed in peripheral blood and tissue Favorable safety profile with single target doses up to 30 µg as well as initial multi-dose regimen Data from the first RA multi-dose regimen cohort and initial clinical data for velinotamig, a BCMAxCD3 T cell engager, to be shared at Cullinan’s Immunology Day on June 10 CAMBRIDGE, Mass., June 06, 2026 (GLOBE NEWSWIRE) — Cullinan Therapeutics, Inc. (Nasdaq: CGEM), a clinical-stage biopharmaceutical company accelerating potential first- or best-in-class, disease-modifying T cell engagers in autoimmune diseases and cancer, announced today that it will present initial clinical data...

Continue reading

Jura Provides Update on Dutch Attachment Proceedings

CALGARY, Alberta, June 05, 2026 (GLOBE NEWSWIRE) — Jura Energy Corporation (“Jura” or the “Company“) announces that the District Court of The Hague, Netherlands (the “Court”), has issued a judgment in summary proceedings ordering the lifting of the pre-judgment third-party attachments previously obtained by Frontier Holdings Limited (“FHL“) and Spud Energy Pty Limited (“Spud“), wholly-owned subsidiaries of the Company. The attachments were over certain rights of Petroleum Exploration (Private) Limited (“PEL“) under agreements PEL had with KUFPEC Pakistan Holdings B.V. and Kirthar Pakistan B.V. (together “KUFPEC“) and were in support of the enforcement of arbitral awards rendered against PEL and in favour of FHL and Spud. The summary proceedings were initiated...

Continue reading

InterPrivate Investment Partners V, Inc. Announces Closing of $201.25 Million Initial Public Offering

New York, NY, June 05, 2026 (GLOBE NEWSWIRE) — InterPrivate Investment Partners V, Inc. (the “Company”), a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities, announced the closing of its initial public offering of 20,125,000 units, including 2,625,000 units issued pursuant to the exercise of the underwriters’ over-allotment option in full, at a price of $10.00 per unit on June 5, 2026. Total gross proceeds from the offering were $201.25 million before deducting underwriting discounts and commissions and other offering expenses payable by the Company. The units began trading on The Nasdaq Global Market (“Nasdaq”) under the ticker symbol “IPVVU” on June 4, 2026. Each...

Continue reading

Argo Corporation Announces Closing of Strategic Investment

TORONTO, June 05, 2026 (GLOBE NEWSWIRE) — Argo Corporation (TSXV: ARGH), (OTCQX: ARGHF) (“Argo” or the “Company”), a leader in next-generation transit solutions, announces that it has closed a non-brokered private placement with a strategic investor whose business is related to the manufacturing of potential future vehicle hardware. Argo continues to advance its next-generation public transit platform and evaluate opportunities to develop alignment with partners and investors in support of its long-term vehicle hardware and fleet strategy. The private placement consisted of 1,150,000 common shares issued at a price of $0.40 per common share, for gross proceeds of $460,000. No finder’s fees or commissions were paid in connection with the private placement. The Company intends to use the proceeds from the private placement for working...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.